Anti-HAV Total Antibody

Brief Description

The HAVAB-G assay is a chemiluminescence immunoassay (CLIA) for the qualitative detection of IgG antibody to hepatitis A virus (IgG anti-HAV) in human serum from patients with signs and symptoms or at risk for hepatitis. The HAVAB-G assay is used to determine the immune status of individuals to hepatitis A virus infection. A positive HAVAB-G test result will reflex to the HAVAB-M assay.  The HAVAB-M assay is a chemiluminescence immunoassay (CLIA) for the qualitative detection of IgM antibody to hepatitis A virus (IgM anti-HAV). A test for IgM anti-HAV is indicated for testing of specimens from individuals who have signs and symptoms consistent with acute hepatitis. Test results are used in conjunction with other laboratory results and clinical information as an aid in the diagnosis of acute or recent Hepatitis A viral infection.

Laboratory Unit



Chemiluminescence Immunoassay (CLIA)

Specimen Collection


Collect in gold top SST tube, centrifuge

Collect in tiger top SST tube, centrifuge


Serum separated from the clot can be maintained at refrigerated temperature (2-8°C) during transit for no more than three days after collection.  Serum separated from the clot can be aliquoted, stored frozen (-20°C or colder) and shipped with dry ice.

Acceptable Specimen Type(s)


Test Request

Possible Results

  • Positive
  • Negative
  • Unsatisfactory
  • Indeterminate

Reference Range


Unacceptable Conditions

  • Missing testing requisition
  • Missing minimum of 2 patient identifiers
  • Improper labeling
  • Improper storage/transport of specimen
  • No specimen received (empty collection tube).
  • Wrong specimen type
  • Low volume
  • Specimen damaged, broken, or leaking upon arrival
  • Specimen grossly hemolyzed, lipemic, turbid, or contaminated
  • Plasma Samples
  • Specimen over 7 days old

Interfering Substances


Result Reported

5-7 business days


Download this pdf file. Fee Schedule

LOINC/Order Codes

20575-7 (Order code: 1400)